The neuroprotective effects of erythropoietin following traumatic brain injury in rats through the AMP-activated protein kinase pathway: A behavioral, biochemical, and histological study
Behavioural Brain Research · 2026
DOI: 10.1016/j.bbr.2025.115943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Brain Research, 2026. Verfasst von Erfan Ghadirzadeh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Non-Communicable Diseases Institute, Mazandara…. Hauptthemen laut MEDLINE: Erythropoietin, Brain Injuries, Traumatic, Neuroprotective Agents, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: While some animal studies have shown that erythropoietin (EPO) can reduce neuronal death and improve cognitive outcomes after traumatic brain injury (TBI), inconsistencies exist in research findings, possibly due to differences in dosage, timing, and injury models. Specifically, the role of EPO in modulating the AMP-activated protein kinase (AMPK) pathway remain unclear. Thus, this study aims to address these gaps by investigating the effects of EPO on neurobehavioral outcomes, brain edema, blood-brain barrier (BBB) permeability, and the AMPK pathway in a severe TBI rat model. METHODS: 112 male Albino Wistar rats were traumatized by free-fall weight dropping Marmarou TBI induction method in eight groups (14 rats each): Intact, Sham, TBI, Saline (TBI + saline injection as placebo), intraperitoneal injection of EPO in 2500, 5000, and 10000 IU/kg doses, and Compound-C (TBI + Compound-C + EPO 5000) group. Cerebral edema, BBB permeability (via Evans blue method), veterinary coma scale (VCS), beam-walk (BW), beam-balance (BB), and p-AMPK/AMPK ratio (through enzyme-linked immunosorbent assay) were evaluated after trauma. RESULTS: Administration of EPO at 2500 and 5000 IU/kg yielded lower brain water content, improved BBB integrity, better VCS, BW, and BB scores, and higher p-AMPK/AMPK ratio (all P < 0.01). Though the 5000 IU/kg dose was also effective, the 2500 IU/kg dose exhibited superior results. Notably, an escalation to 10000 IU/kg or addition of Compound-C worsened the results, suggesting a dose-dependent threshold for EPO's efficacy, and the potential role of AMPK pathway, respectively. CONCLUSION: Our results suggest that EPO may exert neuroprotective effects in TBI-induced rats via modification of the AMPK pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: er.g…
- Student Research Committee, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
- Department of Pharmacology Sciences, School of Pharmacy, Mazandaran University of Medical Sciences, Ramsar, Iran.
- Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran; Department of Medical Laboratory Sciences, Razi Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
- Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
- Immunogenetics Research Center, Department of Physiology, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: ak57n@yahoo.com.
Zitieren
APA
Ghadirzadeh, E., Salehi Mashhad Sari, S. P., Saed, S., Gheibi, M., Asadi Rad, A., Rahimi Bidrouni, S., Mohseni, G., & Siahposht-Khachaki, A. (2026). The neuroprotective effects of erythropoietin following traumatic brain injury in rats through the AMP-activated protein kinase pathway: A behavioral, biochemical, and histological study. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2025.115943
Vancouver
Ghadirzadeh E, Salehi Mashhad Sari SP, Saed S, Gheibi M, Asadi Rad A, Rahimi Bidrouni S, et al. The neuroprotective effects of erythropoietin following traumatic brain injury in rats through the AMP-activated protein kinase pathway: A behavioral, biochemical, and histological study. Behavioural Brain Research. 2026. doi:10.1016/j.bbr.2025.115943
BibTeX
@article{Ghadirzadeh2026,
author = {Ghadirzadeh, Erfan and Salehi Mashhad Sari, Seyed Pooria and Saed, Saeed and Gheibi, Mobina and Asadi Rad, Arya and Rahimi Bidrouni, Samaneh and Mohseni, Ghazal and Siahposht-Khachaki, Ali},
title = {The neuroprotective effects of erythropoietin following traumatic brain injury in rats through the AMP-activated protein kinase pathway: A behavioral, biochemical, and histological study},
journal = {Behavioural Brain Research},
year = {2026},
doi = {10.1016/j.bbr.2025.115943}
}
EUVIMED